(Q52245488)
Statements
A strategy for dose-finding and safety monitoring based on efficacy and adverse outcomes in phase I/II clinical trials. (English)
1 reference
Thall PF
1 reference
Russell KE
1 reference
1 March 1998
1 reference
1 reference
54
1 reference
1
1 reference
251-264
1 reference
Identifiers
1 reference